MetaADEDB 2.0 @ LMMD
rasagiline
(JDBJJCWRXSVHOQ-UTONKHPSSA-N)
Structure
SMILES
CS(=O)(=O)O.C#CCN[C@@H]1CCc2c1cccc2
Molecular Formula:
C13H17NO3S
Molecular Weight:
267.344
Log P:
2.8724
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
74.78
CAS Number(s):
161735-79-1
Synonym(s)
1.
rasagiline
2.
2,3-dihydro-N-2-propynyl-1H-inden-1-amine-(1R)-hydrochloride
3.
AGN 1135
4.
AGN-1135
5.
Azilect
6.
N-2-propynyl-1-indanamine
7.
N-propargyl-1-aminoindan mesylate
8.
TVP 101
9.
TVP 1022
10.
TVP-101
11.
TVP-1022
12.
TVP1022
13.
rasagiline hydrochloride
External Link(s)
MeSHC031967
PubChem Compound3052775
CHEMBLCHEMBL1201142
KEGGdr:D02562
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
2DizzinessFAERS: 33US FAERS
3TremorFAERS: 24US FAERS
4HeadacheFAERS: 20US FAERS
5PneumoniaFAERS: 17US FAERS
6SomnolenceFAERS: 17US FAERS
7FatigueFAERS: 16US FAERS
8AlopeciaFAERS: 15US FAERS
9Weight decreasedFAERS: 15US FAERS
10Myocardial InfarctionFAERS: 13US FAERS
11AnxietyFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
12ConstipationFAERS: 12US FAERS
13MalaiseFAERS: 12US FAERS
14ArthralgiaFAERS: 11US FAERS
15Feeling abnormalFAERS: 11US FAERS
16NauseaFAERS: 11US FAERS
17Musculoskeletal stiffnessFAERS: 8US FAERS
18PalpitationsFAERS: 8US FAERS
19Adverse eventFAERS: 7US FAERS
20ArthropathyFAERS: 7US FAERS
21AstheniaFAERS: 7US FAERS
22Atrial FibrillationFAERS: 7US FAERS
23HypotensionFAERS: 7US FAERS
24Back PainFAERS: 6US FAERS
25Joint swellingFAERS: 5US FAERS
26PsoriasisFAERS: 5US FAERS
27Serotonin SyndromeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Urinary tract infectionFAERS: 5US FAERS
29Blood urine presentFAERS: 4US FAERS
30Cerebrovascular accidentFAERS: 4US FAERS
31NasopharyngitisFAERS: 4US FAERS
32Neck PainFAERS: 4US FAERS
33Oropharyngeal painFAERS: 4US FAERS
34PainFAERS: 4US FAERS
35SyncopeFAERS: 4US FAERS
36AbasiaFAERS: 3US FAERS
37AngerFAERS: 3US FAERS
38Cerebral InfarctionFAERS: 3US FAERS
39DementiaFAERS: 3US FAERS
40Depressed moodFAERS: 3US FAERS
41DysgeusiaFAERS: 3US FAERS
42FractureFAERS: 3US FAERS
43Impaired self-careFAERS: 3US FAERS
44Incorrect dose administeredFAERS: 3US FAERS
45Muscle RigidityFAERS: 3US FAERS
46MyalgiaFAERS: 3US FAERS
47NervousnessFAERS: 3US FAERS
48Peripheral swellingFAERS: 3US FAERS
49Renal painFAERS: 3US FAERS
50Sudden onset of sleepFAERS: 3US FAERS
51UrticariaFAERS: 3US FAERS
52Visual ImpairmentFAERS: 3US FAERS
53Abdominal PainFAERS: 2US FAERS
54Abdominal discomfortFAERS: 2US FAERS
55Accidental overdoseFAERS: 2US FAERS
56Angina PectorisFAERS: 2US FAERS
57ApathyFAERS: 2US FAERS
58AphasiaFAERS: 2US FAERS
59AphoniaFAERS: 2US FAERS
60Back disorderFAERS: 2US FAERS
61BlindnessFAERS: 2US FAERS
62Burning sensationFAERS: 2US FAERS
63Cerebral hypoperfusionFAERS: 2US FAERS
64Chest PainFAERS: 2US FAERS
65Chest discomfortFAERS: 2US FAERS
66Cold sweatFAERS: 2US FAERS
67Dental cariesFAERS: 2US FAERS
68Drug dose omissionFAERS: 2US FAERS
69Drug withdrawal syndromeFAERS: 2US FAERS
70DysarthriaFAERS: 2US FAERS
71DyspepsiaFAERS: 2US FAERS
72Erectile dysfunctionFAERS: 2US FAERS
73ErythemaFAERS: 2US FAERS
74FlatulenceFAERS: 2US FAERS
75GamblingFAERS: 2US FAERS
76GoutFAERS: 2US FAERS
77HypokinesiaFAERS: 2US FAERS
78Impaired driving abilityFAERS: 2US FAERS
79Inappropriate schedule of drug administrationFAERS: 2US FAERS
80Intestinal ObstructionFAERS: 2US FAERS
81LymphomaFAERS: 2US FAERS
82Musculoskeletal PainFAERS: 2US FAERS
83NephrolithiasisFAERS: 2US FAERS
84PallorFAERS: 2US FAERS
85PhotophobiaFAERS: 2US FAERS
86Product prescribing errorFAERS: 2US FAERS
87PruritusFAERS: 2US FAERS
88Respiratory FailureFAERS: 2US FAERS
89Respiratory arrestFAERS: 2US FAERS
90Restless Legs SyndromeFAERS: 2US FAERS
91VomitingFAERS: 2US FAERS
92AbscessFAERS: 1US FAERS
93Accidental drug intake by childFAERS: 1US FAERS
94Acute myocardial infarctionFAERS: 1US FAERS
95AgitationFAERS: 1US FAERS
96Altered state of consciousnessFAERS: 1US FAERS
97Anaphylactic shockFAERS: 1US FAERS
98AngioedemaFAERS: 1US FAERS
99AnorgasmiaFAERS: 1US FAERS
100AphagiaFAERS: 1US FAERS
101ArteriosclerosisFAERS: 1US FAERS
102AsterixisFAERS: 1US FAERS
103AsthenopiaFAERS: 1US FAERS
104BedriddenFAERS: 1US FAERS
105Blood antidiuretic hormone decreasedFAERS: 1US FAERS
106Blood creatinine increasedFAERS: 1US FAERS
107Blood glucose decreasedFAERS: 1US FAERS
108Blood testosterone decreasedFAERS: 1US FAERS
109Blood urea increasedFAERS: 1US FAERS
110Bowel movement irregularityFAERS: 1US FAERS
111Bronchopulmonary diseaseFAERS: 1US FAERS
112Cardiac ArrestFAERS: 1US FAERS
113CardiomegalyFAERS: 1US FAERS
114Cheyne-Stokes RespirationFAERS: 1US FAERS
115ChillsFAERS: 1US FAERS
116ChokingFAERS: 1US FAERS
117Completed SuicideFAERS: 1US FAERS
118Cranial operationFAERS: 1US FAERS
119CryingFAERS: 1US FAERS
120Cytolytic hepatitisFAERS: 1US FAERS
121DehydrationFAERS: 1US FAERS
122Depressed Level of ConsciousnessFAERS: 1US FAERS
123Diabetes MellitusFAERS: 1US FAERS
124DiscomfortFAERS: 1US FAERS
125Disease ProgressionFAERS: 1US FAERS
126DisorientationFAERS: 1US FAERS
127DiverticulumFAERS: 1US FAERS
128Drug DependenceFAERS: 1US FAERS
129Drug level increasedFAERS: 1US FAERS
130Drug prescribing errorFAERS: 1US FAERS
131Dry skinFAERS: 1US FAERS
132DysgraphiaFAERS: 1US FAERS
133DysphoniaFAERS: 1US FAERS
134DystoniaFAERS: 1US FAERS
135EpistaxisFAERS: 1US FAERS
136EructationFAERS: 1US FAERS
137Expired drug administeredFAERS: 1US FAERS
138Eye painFAERS: 1US FAERS
139Female Orgasmic DisorderFAERS: 1US FAERS
140FlushingFAERS: 1US FAERS
141FormicationFAERS: 1US FAERS
142Gastric ulcerFAERS: 1US FAERS
143Head discomfortFAERS: 1US FAERS
144Heat StrokeFAERS: 1US FAERS
145Hepatic EncephalopathyFAERS: 1US FAERS
146HungerFAERS: 1US FAERS
147HypersensitivityFAERS: 1US FAERS
148Hypertensive crisisFAERS: 1US FAERS
149HypophagiaFAERS: 1US FAERS
150Idiopathic Pulmonary FibrosisFAERS: 1US FAERS
151Inability to afford medicationFAERS: 1US FAERS
152IncontinenceFAERS: 1US FAERS
153Incorrect route of drug administrationFAERS: 1US FAERS
154InfarctionFAERS: 1US FAERS
155InfectionFAERS: 1US FAERS
156InfluenzaFAERS: 1US FAERS
157Intentional product misuseFAERS: 1US FAERS
158Intervertebral disc disorderFAERS: 1US FAERS
159Irregular sleep phaseFAERS: 1US FAERS
160Lacrimation decreasedFAERS: 1US FAERS
161LethargyFAERS: 1US FAERS
162Limb injuryFAERS: 1US FAERS
163Limb operationFAERS: 1US FAERS
164Lip swellingFAERS: 1US FAERS
165Malignant melanoma stage IIFAERS: 1US FAERS
166MenorrhagiaFAERS: 1US FAERS
167Mental impairmentFAERS: 1US FAERS
168MoaningFAERS: 1US FAERS
169NeutropeniaFAERS: 1US FAERS
170Obsessive-Compulsive DisorderFAERS: 1US FAERS
171Orthodontic procedureFAERS: 1US FAERS
172Orthostatic intoleranceFAERS: 1US FAERS
173OverdoseFAERS: 1US FAERS
174Pancreatic carcinomaFAERS: 1US FAERS
175Pancreatic enzymes increasedFAERS: 1US FAERS
176ParanoiaFAERS: 1US FAERS
177Parenteral NutritionFAERS: 1US FAERS
178PemphigusFAERS: 1US FAERS
179Pericardial effusionFAERS: 1US FAERS
180Polymyalgia RheumaticaFAERS: 1US FAERS
181PolyuriaFAERS: 1US FAERS
182Poor quality sleepFAERS: 1US FAERS
183Post procedural infectionFAERS: 1US FAERS
184Postpericardiotomy SyndromeFAERS: 1US FAERS
185PresyncopeFAERS: 1US FAERS
186Product quality issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Product substitution issueFAERS: 1US FAERS
188Product taste abnormalFAERS: 1US FAERS
189Product use issueFAERS: 1US FAERS
190Pupil dilation procedureFAERS: 1US FAERS
191Rash erythematousFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
192RhabdomyosarcomaFAERS: 1US FAERS
193Rheumatoid ArthritisFAERS: 1US FAERS
194Septic ShockFAERS: 1US FAERS
195Skin lacerationFAERS: 1US FAERS
196Skin lesionFAERS: 1US FAERS
197Slow response to stimuliFAERS: 1US FAERS
198Slow speechFAERS: 1US FAERS
199SneezingFAERS: 1US FAERS
200SomnambulismFAERS: 1US FAERS
201Squamous cell carcinoma of skinFAERS: 1US FAERS
202StaringFAERS: 1US FAERS
203StomatitisFAERS: 1US FAERS
204StressFAERS: 1US FAERS
205Sudden deathFAERS: 1US FAERS
206SwellingFAERS: 1US FAERS
207TachyarrhythmiaFAERS: 1US FAERS
208TachycardiaFAERS: 1US FAERS
209Temperature intoleranceFAERS: 1US FAERS
210TensionFAERS: 1US FAERS
211Thermal burnFAERS: 1US FAERS
212TinnitusFAERS: 1US FAERS
213Tooth ErosionFAERS: 1US FAERS
214Tyramine reactionFAERS: 1US FAERS
215Ulnar Nerve PalsyFAERS: 1US FAERS
216Unevaluable eventFAERS: 1US FAERS
217Urinary RetentionFAERS: 1US FAERS
218VasculitisFAERS: 1US FAERS
219VertigoFAERS: 1US FAERS
220Wrong technique in product usage processFAERS: 1US FAERS
221colonoscopyFAERS: 1US FAERS
222liposarcomaFAERS: 1US FAERS
223DeliriumCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.